| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter, open-label phase Ib/II study of cadonilimab (anti PD-1 and CTLA-4 bispecific antibody) monotherapy in previously treated advanced non–small-cell lung cancer (AK104-202 study)
|
Zhao, Yuanyuan
|
|
|
184 |
C |
p.
|
artikel
|
| 2 |
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications
|
Seker-Cin, Huriye
|
|
|
184 |
C |
p.
|
artikel
|
| 3 |
A problem with clinical T factor in the 8th TNM edition: Prognosis and EGFR mutation status of small sized lung cancers with difficulty to measure the diameter of solid component in part-solid tumor
|
Matsunaga, Takeshi
|
|
|
184 |
C |
p.
|
artikel
|
| 4 |
A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancer
|
Zhang, Wei
|
|
|
184 |
C |
p.
|
artikel
|
| 5 |
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations
|
Ninomiya, Takashi
|
|
|
184 |
C |
p.
|
artikel
|
| 6 |
Association of telomere length with risk of lung cancer: A large prospective cohort study from the UK Biobank
|
Han, Duoduo
|
|
|
184 |
C |
p.
|
artikel
|
| 7 |
Balancing tumour control probability and toxicity in SBRT of ultra-central lung tumours – One step forward
|
Lindberg, Karin
|
|
|
184 |
C |
p.
|
artikel
|
| 8 |
Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics
|
Cho, In Sung
|
|
|
184 |
C |
p.
|
artikel
|
| 9 |
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score
|
Ziranu, Pina
|
|
|
184 |
C |
p.
|
artikel
|
| 10 |
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients
|
Glaser, Moritz
|
|
|
184 |
C |
p.
|
artikel
|
| 11 |
Comparative bioinformatic analysis of KRAS, STK11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C
|
Boeschen, Myriam
|
|
|
184 |
C |
p.
|
artikel
|
| 12 |
Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: Systematic review and network meta-analysis
|
Luo, Yuyao
|
|
|
184 |
C |
p.
|
artikel
|
| 13 |
Contents
|
|
|
|
184 |
C |
p.
|
artikel
|
| 14 |
Cost-effectiveness analysis of atezolizumab as adjuvant treatment of patients with stage II-IIIA non-small cell lung cancer, PD-L1+≥50% of tumor cells in France: A modeling study
|
Plessala, Ingrid
|
|
|
184 |
C |
p.
|
artikel
|
| 15 |
Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer
|
Zeng, Liang
|
|
|
184 |
C |
p.
|
artikel
|
| 16 |
Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer
|
Alkan Şen, Gülin
|
|
|
184 |
C |
p.
|
artikel
|
| 17 |
Efficacy and safety of re-challenging 160 mg furmonertinib for advanced NSCLC after resistance to third-generation EGFR-TKIs targeted agents: A real-world study
|
Qi, Rongbin
|
|
|
184 |
C |
p.
|
artikel
|
| 18 |
Efficacy and surgical safety of sequential surgical resection after pembrolizumab plus chemotherapy for initial unresectable stage IIIB non-small cell lung cancer
|
Zheng, Jing
|
|
|
184 |
C |
p.
|
artikel
|
| 19 |
High levels of expression of Trop-2 in thymic epithelial tumors
|
Yeung, Vincent
|
|
|
184 |
C |
p.
|
artikel
|
| 20 |
Immune checkpoint inhibitors in non-small cell lung cancer – When should we dare to stop treatment?
|
Bozorgmehr, Farastuk
|
|
|
184 |
C |
p.
|
artikel
|
| 21 |
Immune-related acute kidney injury in Australian non-small cell lung cancer patients: Real-world results
|
Knox, Andrea
|
|
|
184 |
C |
p.
|
artikel
|
| 22 |
Immunogenicity of COVID-19 vaccines in lung cancer patients
|
Provencio, Mariano
|
|
|
184 |
C |
p.
|
artikel
|
| 23 |
Impact of first-line immunotherapy on survival and intracranial outcomes in a cohort of non-small cell lung cancer patients with brain metastases at diagnosis
|
Nigen, Benoit
|
|
|
184 |
C |
p.
|
artikel
|
| 24 |
Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer
|
Ku, Hsiu-Ying
|
|
|
184 |
C |
p.
|
artikel
|
| 25 |
Impact of skip mediastinal lymph node metastasis on outcomes after resection for primary lung cancer
|
Taylor, Marcus
|
|
|
184 |
C |
p.
|
artikel
|
| 26 |
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
|
Lim, Tony Kiat Hon
|
|
|
184 |
C |
p.
|
artikel
|
| 27 |
Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases
|
Yan, Xin
|
|
|
184 |
C |
p.
|
artikel
|
| 28 |
Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics
|
Goto, Eisuke
|
|
|
184 |
C |
p.
|
artikel
|
| 29 |
Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer
|
Murata, Daiki
|
|
|
184 |
C |
p.
|
artikel
|
| 30 |
The search for therapeutic targets in lung cancer: Preclinical and human studies of carcinoembryonic antigen-related cell adhesion molecule 5 expression and its associated molecular landscape
|
Lefebvre, Anne-Marie
|
|
|
184 |
C |
p.
|
artikel
|
| 31 |
Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages
|
Ho, Hao
|
|
|
184 |
C |
p.
|
artikel
|
Tijdschrift beschrijving